Findings from University of Illinois in the Area of Solid Cancer Described [Phase I Study of Aurora a Kinase Inhibitor Alisertib (Mln8237) In Combination With Selective Vegfr Inhibitor Pazopanib for Therapy of Advanced Solid Tumors]

Source :: Obesity, Fitness & Wellness Week. September 14, 2019, 778
Publication Year :: 2019
Abstract: 2019 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Oncology - Solid Cancer. According to news [...]

Subjects :: Millennium Pharmaceuticals Inc.
Drug therapy
Research
Physical fitness
Angiogenesis inhibitors -- Research
Endothelial growth factors
Cancer -- Drug therapy
Cancer research
Biotechnology industries
Pazopanib -- Research
Obesity
Tumors
Editors

Tools